Inglis Tiffany Eul Davis
Officer at SERA
- Sold, on record
- $2k
- Dollars the filings state
- Form 4 sales
- 2
- Latest Sep 10, 2026
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- SERASERA PROGNOSTICS, INC.Officer
Sales by reason
0
Routine
0
Plan not stated
2
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale SERANo planJun 11, 2026 2026
Sold 362 shares at $2.01 ($728)
Inglis Tiffany Eul Davis, Chief Medical Officer
No 10b5-1 planSold 0.4% of holdings ($186k position)92,075 shares leftFirst sale on recordFiling
- 2 Form 144 notice SERANoticeJun 15, 2026 +4 days
Filed to sell 362 shares ($726)
Inglis Tiffany Eul Davis, Officer
No 10b5-1 planFiling
- 3 Form 4 sale SERANo planSep 10, 2026 +87 days
Sold 486 shares at $2.00 ($972)
Inglis Tiffany Eul Davis, Chief Medical Officer
No 10b5-1 planSold 0.5% of holdings ($184k position)91,589 shares leftFollows a Form 144Filing
- 4 Form 144 notice SERANoticeSep 11, 2026 +1 day
Filed to sell 486 shares ($972)
Inglis Tiffany Eul Davis, Officer
No 10b5-1 planFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | Sep 11, 2026 | SERA | Officer | Form 144 notice | 486 | $972 | Notice | SEC | |
| Sep 10, 2026 | Sep 11, 2026 | SERA | Chief Medical Officer | Form 4 sale | 486 | $972 | 0.5% | No plan | SEC |
| Jun 15, 2026 | Jun 15, 2026 | SERA | Officer | Form 144 notice | 362 | $726 | Notice | SEC | |
| Jun 11, 2026 | Jun 15, 2026 | SERA | Chief Medical Officer | Form 4 sale | 362 | $728 | 0.4% | No plan | SEC |